Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Headlines I would like to see:

PTSC announces completion of stock buy back program reducing outstanding shares from 400 million to 300 million shares at a cost of $10 million dollars.

PTSC announces this quarter dividend of ten cents at a cost of $30 million dollars.

Then next quarter:

PDSG announces contracts with 5 different Federal agencies to implement data systems in partnership with HP and

PTSC announces another dividend of ten cents at a cost of $30 million dollars (half of the revenue brought in this quarter by the MMP).

I am sure these headlines would make me smile.

Share
New Message
Please login to post a reply